Placenta mesenchymal stem cell injection, preparation method and application thereof
A kind of stem cell and injection technology, applied in the field of stem cells, can solve the problems of low immunogenicity and less application, and achieve the effects of low immunogenicity, strong proliferation ability, and convenient material acquisition.
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0072] Embodiment 1 Preparation method of placental mesenchymal stem cells
[0073] 1. Primary isolation of placental mesenchymal stem cells
[0074] Under sterile conditions, take the fresh placenta discarded after delivery, peel off the placenta, wash it with PBS buffer solution, and cut the placenta tissue into 5×5cm 2 , add 3-5 times the volume of 0.25% trypsin to digest, place on a 200r / min 37°C constant temperature shaker, digest for 30min, and shake vigorously several times every 10min to remove epithelial cells.
[0075] After the digestion is complete, transfer it to a storage bottle, add 150 mL of PBS buffer solution, shake vigorously, and repeat this operation 2 times. Transfer placental tissue to a small beaker and chop to 1mm 3 . Then transfer to a storage bottle, add 20 mL of 0.5% type I collagenase and complete medium (high glucose DMEM+10% FBS), so that the final concentration of collagenase is 0.1-0.2%. Place in a constant temperature shaker at 37°C, 250r / ...
Embodiment 2
[0088] The preparation of embodiment 2 placental mesenchymal stem cell injection
[0089] Prepare 100mL stem cell injection: albumin concentration is 20% human serum albumin stock solution 15mL (mass volume ratio final concentration is 3%), vitamin C 0.5g (mass volume ratio final concentration is 0.5%), pearl ginsenoside 6g ( Mass volume ratio final concentration is 6%) and 0.9% sodium chloride injection 75mL are mixed, placental mesenchymal stem cells (cell suspension after recovery is 10mL, contains DMSO 1mL, FBS 9mL, cell final concentration 1×10 6 pcs / mL) in the mixture and resuspended to complete the preparation.
[0090] The reserved samples of the placental mesenchymal stem cell injection prepared above are tested for endotoxin, bacteria and fungi, and mycoplasma. If the test results are all negative, it is qualified.
Embodiment 3
[0091] The preparation of embodiment 3 placental mesenchymal stem cell injection
[0092] Prepare 100mL stem cell injection: albumin concentration is 20% human serum albumin stock solution 5mL (mass volume ratio final concentration is 1%), vitamin C 0.3g (mass volume ratio final concentration is 0.3%), pearl ginsenoside 2g ( Mass volume ratio final concentration is 2%) mixed with 0.9% sodium chloride injection 85mL, placental mesenchymal stem cells (cell suspension after recovery is 10mL, containing DMSO 0.5mL, FBS 4.5mL, cell final concentration 1× 10 6 pcs / mL) in the mixture and resuspended to complete the preparation.
[0093] The reserved samples of the placental mesenchymal stem cell injection prepared above are tested for endotoxin, bacteria and fungi, and mycoplasma. If the test results are all negative, it is qualified.
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com